Prenumeration för 2 €

Från 2 euro säkra

Financial Data API

Terminal Financial Data API

Affimed Aktie News & Pressemeldungen

Affimed Eulerpool Nyheter

2024-12-06 11:42:05

FDA stärkt Hoffnung für Patient:innen mit fortgeschrittener Lymphomtherapie

1

1

Affimed Aktiens nyheter

Affimed bevakas av många journalister och investerare över hela världen. De senaste Affimed nyheterna samlar vi här.

17 december ·
Yahoo
Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)
9 december ·
Yahoo
Affimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination with Atezolizumab in Non-Small Cell Lung Cancer
8 december ·
Yahoo
Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients
6 december ·
Yahoo
FDA ARMAT status for Affimed and Artiva’s lymphoma combo therapy
5 december ·
Yahoo
Affimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA)
15 november ·
Yahoo
Affimed NV (AFMD) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges with ...
14 november ·
SeekingAlpha
Affimed N.V. (AFMD) Q3 2024 Earnings Call Transcript
14 november ·
Yahoo
Affimed N.V.: Q3 Earnings Snapshot
14 november ·
Yahoo
Affimed Reports Third Quarter 2024 Financial Results & Business Update
14 november ·
SeekingAlpha
Affimed N.V. 2024 Q3 - Results - Earnings Call Presentation

1

2

1

2

Affimed Aktie Pressmeddelanden

Affimed publicerar regelbundet meddelanden som är relevanta för investerare på företagets webbplats.

Gör de bästa investeringarna i ditt liv

Från 2 euro säkra